The firms will continue to develop strains of algae that demonstrate improved photosynthetic efficiency and oil production.
The agency expects existing programs to guide its regulation, adding that modified portions of animal genomes would be considered drugs.
The firm has secured rights to use CRISPR in cell lines for biomanufacturing and will work with Solentim to increase editing throughput while decreasing costs.
Researchers described the development and testing of layered double hydroxide nanosheets as carriers for RNAi molecules in agriculture.
NIH researchers got tantalizingly close to long-term engraftment at levels that could provide a clinical benefit in gene therapy applications.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.